cerrar
Tagged with strategy

Andrew Hexter – Vice President & General Manager Asia…
Andrew Hexter, VP and GM of Gilead Asia 5 (Hong Kong, Singapore, South Korea, Taiwan and Malaysia), shares the highlights of his past three years…

Joong Myung Cho – Chairman & CEO, CrystalGenomics,…
Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery platform, key growth factors, highly…

Michael G. Kauffman – Founder & CEO, Karyopharm…
Karyopharm Therapeutics’ Dr Michael G. Kauffman outlines the genesis of the company he co-founded with his wife, the approval journey of key product…

Eli Lilly and Innovent take China Partnership Global
The partnership between global pharma giant Eli Lilly and Chinese biotech Innovent Biologics, first initiated in March 2015, continues to bear…

Kerry Blanchard – CEO, Everest Medicines, China
Dr Kerry Blanchard explains why he took on the challenge of becoming CEO of Chinese biotech Everest Medicines and how Everest’s internationalist…

Ivan Cheung – Chairman, Eisai Inc.; President, Neurology…
Ivan Cheung, head of Japanese firm Eisai’s US operations, highlights the significance of a potential 2021 US FDA approval for Alzheimer’s Disease…

Lundbeck US Head on COVID-19’s Dramatic Mental Health Impact
PharmaBoardroom recently spoke to CNS-focused Danish biopharma company Lundbeck’s EVP and Head of North America Peter Anastasiou, who highlighted…

Company Spotlight: I-Mab Biopharma
The only company in our Summer 2020 edition of InFocus: 5 Biotechs to Watch in China to be helmed by a non-founding CEO, I-Mab Biopharma has advanced…

Kristel de Bisschop – General Manager, Pierre Fabre Benelux
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in taking charge of an important…

Peter Anastasiou – Executive VP & Head of North…
Industry veteran Peter Anastasiou, executive VP and head of North America for Danish CNS specialist Lundbeck, outlines the performance of Lundbeck’s…

Kevin Houdenaert – General Manager, Recordati Benelux…
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care specialist Recordati, gives an…

Sanofi Genzyme Head on Incredible Success of…
Sanofi's inflammation drug Dupixent® is driving a substantial percentage of the firm's sales in 2020, reaching USD 1.92 billion in the first half of…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here